| __timestamp | AstraZeneca PLC | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 293000 |
| Thursday, January 1, 2015 | 5997000000 | 1002000 |
| Friday, January 1, 2016 | 5890000000 | 888000 |
| Sunday, January 1, 2017 | 5757000000 | 19623000 |
| Monday, January 1, 2018 | 5932000000 | 30421000 |
| Tuesday, January 1, 2019 | 5958000000 | 34794000 |
| Wednesday, January 1, 2020 | 5991000000 | 28304000 |
| Friday, January 1, 2021 | 9736000000 | 56886000 |
| Saturday, January 1, 2022 | 9762000000 | 100894000 |
| Sunday, January 1, 2023 | 10935000000 | 159765000 |
| Monday, January 1, 2024 | 13583000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) investment is a critical driver of innovation and growth. Over the past decade, AstraZeneca PLC has consistently demonstrated its commitment to R&D, with expenditures increasing by nearly 96% from 2014 to 2023. In contrast, Viridian Therapeutics, Inc., a smaller player, has shown a remarkable growth trajectory, with R&D spending skyrocketing by over 54,000% during the same period.
AstraZeneca's robust investment strategy, peaking at approximately $10.9 billion in 2023, underscores its focus on pioneering treatments and maintaining its competitive edge. Meanwhile, Viridian's exponential growth, reaching around $160 million in 2023, highlights its aggressive push to innovate and expand its therapeutic portfolio. This comparison not only reflects the diverse strategies of these companies but also illustrates the dynamic nature of the pharmaceutical industry.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.